Neoadjuvant Nivolumab-Ipilimumab Could Be New Standard Care in dMMR Colon Cancer
Neoadjuvant nivolumab and ipilimumab produced an “unprecedented” major pathologic response rate in the NICHE-2 study, according to the lead study author.
Neoadjuvant nivolumab and ipilimumab produced an “unprecedented” major pathologic response rate in the NICHE-2 study, according to the lead study author.
In a study of end-of-life care for children with cancer, healthcare resource use measures were seen as less important than were patient-reported outcomes.
Researchers review effective strategies for screening, assessment, and management of depression in patients with cancer.
A report examines a newly created role in nursing care for managing patient care during chimeric antigen receptor T-cell therapy in the outpatient setting.
Matched cohort study showed risk greatest for those with primary myelofibrosis, but still high for those with polycythemia vera and essential thrombocythemia.
Roles for advance practice registered nurses are expanding in cancer centers.
Nurse practitioners play an essential role in the chemotherapy plan for patients with cancer.
Researchers attempted to develop a predictive model for the risk of postpartum hemorrhage in patients who have ITP.
Results of an assessment of tissue composition changes experienced by breast cancer survivors without lymphedema are presented.
A team of international researchers sought to confirm a “dual pathway hypothesis” for the development of melanoma.